Your browser doesn't support javascript.
Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities.
Li, Xin; Chan, Jacky Man Chun; Lam, Bosco; Lung, David Christopher; Lung, Kwok Cheung; Chow, Christina Kin Yi; Tam, Tracey; Chiu, Kelvin Hei Yeung; Hung, Ling Lung; Hung, Ivan Fan Ngai; Cheng, Vincent Chi Chung; To, Kelvin Kai Wang; Yuen, Kwok Yung.
  • Li X; State Key Laboratory for Emerging Infection Disease, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Chan JMC; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Lam B; Department of Medicine, Princess Margaret Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Lung DC; Department of Microbiology, Princess Margaret Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Lung KC; Department of Pathology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Chow CKY; Department of Pathology, Hong Kong Children's Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Tam T; Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Chiu KHY; Department of Pathology, Queen Elizabeth Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Hung LL; Quality & Safety Division, Hospital Authority, Hong Kong Special Administrative Region, People's Republic of Chinaand.
  • Hung IFN; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • Cheng VCC; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, People's Republic of China.
  • To KKW; Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China.
  • Yuen KY; Department of Microbiology, Queen Mary Hospital, Hong Kong Special Administrative Region, People's Republic of China.
Clin Infect Dis ; 75(1): e905-e908, 2022 Aug 24.
Article in English | MEDLINE | ID: covidwho-1852988
ABSTRACT
This retrospective study of incoming travelers with coronavirus disease 2019 showed that individuals immunized by messenger RNA vaccines had significantly longer postvaccination intervals (median, 30.5 days) to breakthrough infection, lower white blood cell counts and lactate dehydrogenase levels on admission, and fewer radiographic abnormalities than those immunized by inactivated virus vaccine, who paradoxically had lower respiratory viral load.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article